NASDAQ:DBVT
DBV Technologies S.A. Stock News
$0.571
-0.123 (-17.77%)
At Close: May 09, 2024
DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020
08:30pm, Thursday, 04'th Jun 2020
Montrouge, France, June 4, 2020 DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020 Virtual.
DBV Technologies To Present at the Goldman Sachs 41st Annual Global Healthcare Conference
08:30pm, Tuesday, 02'nd Jun 2020
Montrouge, France, June 2, 2020 DBV Technologies To Present at the Goldman Sachs 41st Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345.
DBV Technologies To Present at the Goldman Sachs 4–st Annual Global Healthcare Conference
12:00am, Tuesday, 02'nd Jun 202020 Healthcare Stocks Moving In Thursday's Pre-Market Session
12:00am, Thursday, 21'st May 2020Perceptive Advisors Llc Buys Iovance Biotherapeutics Inc, Zymeworks Inc, Regeneron ...
12:00am, Monday, 18'th May 2020Perceptive Advisors Llc Buys Iovance Biotherapeutics Inc, Zymeworks Inc, Regeneron ...
12:00am, Friday, 15'th May 2020Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020
08:01pm, Tuesday, 12'th May 2020
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020 (Article 223-16 of the General Regulations of the.
